In this study, we retrospectively analysed 38 consecutive patients with resectable stage IIIA NSCLC receiving NACT with/without PD-1 inhibitors followed by radical surgery and made a long-term follow-up to investigate whether MPR could predict prognosis. Here, PDCD1 is linked to non-small cell lung carcinoma.